Literature DB >> 16374052

Maintaining the redox-balance intact: gosha-jinki-gan but not insulin activates retinal soluble guanylate cyclase in diabetic rats.

Silke Cameron-Schaefer1, Kazunari Kondo, Atsushi Ishige, Shingo Tsuyama, Koji Uchida, Toshihiko Hanawa, Makoto Suematsu, Kenji Watanabe.   

Abstract

Strategies to prevent hyperglycemia-induced cytotoxic reactive oxygen species in the retina include the prevention of free radical production, activation of radical-scavenging capacities and inhibition of aldose reductase. This study examined the effect of the standardized Japanese herbal extract product gosha-jinki-gan (GJG) in comparison to insulin treatment in the rat retina. Diabetes was induced in male Wistar rats by single injection of streptozotocin (50 mg/kg i.p.). At 6 and 12 weeks, eye-cups were removed for immunohistochemistry. At 12 weeks, lipid peroxidation (tested with the antiacrolein antibody, Ab5F6) was enhanced significantly in the untreated diabetic group. This effect was absent in both treatment groups, notably in the outer retina. A similar result was obtained for nitrotyrosine overproduction. As an early treatment effect, GJG -- but not insulin -- enhanced soluble guanylate cyclase (sGC) activation (using the function-sensing antibody, MoAb 3221). GJG not only reduces nitroxidative stress and lipid peroxidation in the retina, it also ameliorates glucose metabolism within the cells. We propose that the high glucose turnover in the insulin-treated model disturbs the intracellular redox equilibrium, one result of which might be the impaired sGC activation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16374052     DOI: 10.1159/000090451

Source DB:  PubMed          Journal:  Ophthalmic Res        ISSN: 0030-3747            Impact factor:   2.892


  3 in total

1.  Clinical efficacy and tolerability of Gosha-jinki-gan, a Japanese traditional herbal medicine, for nocturia.

Authors:  Hiroshi Yagi; Kojiro Nishio; Ryo Sato; Gaku Arai; Shigehiro Soh; Hiroshi Okada
Journal:  J Tradit Complement Med       Date:  2015-01-30

2.  A Reduction-Based Sensor for Acrolein Conjugates with the Inexpensive Nitrobenzene as an Alternative to Monoclonal Antibody.

Authors:  Masayuki Takamatsu; Koichi Fukase; Ritsuko Oka; Shinobu Kitazume; Naoyuki Taniguchi; Katsunori Tanaka
Journal:  Sci Rep       Date:  2016-10-26       Impact factor: 4.379

3.  Long-term effects of goshajinkigan in prevention of diabetic complications: a randomized open-labeled clinical trial.

Authors:  K Watanabe; A Shimada; K Miyaki; A Hirakata; K Matsuoka; K Omae; I Takei
Journal:  Evid Based Complement Alternat Med       Date:  2014-04-09       Impact factor: 2.629

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.